Brolucizumab
Product Specifications
CAS Number
1531589-13-5
Target
VEGFR
Related Pathways
Tyrosine Kinase/Adaptors, Angiogenesis
Purity
0.9967
Bioactivity
Brolucizumab (DLX1008) is a single-chain variable fragment (scFv) anti-VEGF-A antibody exhibiting an exceptionally low picomolar binding affinity (K D = 1.05 pM) . through its potent blockade of vascular endothelial growth factor A (VEGF-A), Brolucizumab effectively reduces pathological neovascularization and vascular leakage within the macula and is under investigation for the treatment of neovascular (wet) age-related macular degeneration (AMD) .
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
E-UNEL-H0216-01 5x 96 Tests
Uncoated Human ENG (Endoglin) ELISA Kit
Sign In for Pricing
View Details E-UNEL-H0216-02 15x 96 Tests
Uncoated Human ENG (Endoglin) ELISA Kit
Sign In for Pricing
View Details 
BNC402478-500 1x 500 µL
CD3e (T-Cell Marker) (C3e/2478), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740733-500 1x 500 µL
TAG-72 / CA72.4 (CA72/733), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
